Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 151
- By:
- Publication type:
- Article
Works matching IS 01676997 AND DT 2008 AND VI 26 AND IP 2
Results: 11
1
2
A phase I–II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798)
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 193, doi. 10.1007/s10637-007-9104-1
- By:
- Publication type:
- Article
3
Biotransformation and pharmacokinetics of the novel anticancer drug, SYUIQ-5, in the rat.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 119, doi. 10.1007/s10637-007-9089-9
- By:
- Publication type:
- Article
4
The “old drug” dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 175, doi. 10.1007/s10637-007-9086-z
- By:
- Publication type:
- Article
5
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 139, doi. 10.1007/s10637-007-9106-z
- By:
- Publication type:
- Article
6
Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 159, doi. 10.1007/s10637-008-9112-9
- By:
- Publication type:
- Article
7
Atypical cytostatic mechanism of N -1-sulfonylcytosine derivatives determined by in vitro screening and computational analysis.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 97, doi. 10.1007/s10637-007-9084-1
- By:
- Publication type:
- Article
8
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 183, doi. 10.1007/s10637-007-9091-2
- By:
- Publication type:
- Article
9
NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 111
- By:
- Publication type:
- Article
10
Topical henna for capecitabine induced handâfoot syndrome.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 189, doi. 10.1007/s10637-007-9082-3
- By:
- Publication type:
- Article
11
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine<sup>®</sup>) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 169, doi. 10.1007/s10637-007-9085-0
- By:
- Publication type:
- Article